Relevant functional decline | ||||||
---|---|---|---|---|---|---|
Without decline (n = 1817; 82.2%) | With decline (n = 394; 17.8%) | |||||
Characteristics | n | % | n | % | Odds ratio | 95% CI |
Age in years (median, IQR) | 81.8 (78.5–86.2) | 83.5 (79.8–87.7) | 1.06 | 1.04; 1.08 | ||
Baseline GARS (median, IQR) | 30 (24–39) | 36 (28–49) | 1.04 | 1.03; 1.05 | ||
Sex | ||||||
Male | 559 | 30.8 | 148 | 37.6 | ref | |
Female | 1258 | 69.2 | 246 | 62.4 | 0.74 | 0.59; 0.93 |
Polypharmacy | ||||||
< 4 per day | 603 | 33.2 | 107 | 27.2 | ref | |
4 or more per day | 1214 | 66.8 | 287 | 72.8 | 1.33 | 1.05; 1.70 |
Multimorbidity | ||||||
No | 169 | 9.3 | 31 | 7.9 | ref | |
Yes (> 1 chronic disease) | 1648 | 90.7 | 363 | 92.1 | 1.20 | 0.81; 1.79 |
Living situation | ||||||
Independent, alone/with others | 1656 | 91.1 | 329 | 83.5 | ref | |
Home for older persons | 161 | 8.9 | 65 | 16.5 | 2.03 | 1.49; 2.77 |
GP opinion on vulnerability | ||||||
Not vulnerable | 802 | 44.1 | 92 | 23.4 | ref | |
Possibly vulnerable | 518 | 28.5 | 99 | 25.1 | 1.67 | 1.23; 2.26 |
Vulnerable | 497 | 27.4 | 203 | 51.5 | 3.56 | 2.72; 4.67 |
ISCOPE-score on ISCOPE screening questionnaire | ||||||
0 (no domain with problems) | 179 | 9.9 | 19 | 4.8 | ref | |
1 (1 domain with problems) | 172 | 9.5 | 11 | 2.8 | 0.60 | 0.28; 1.30 |
2 (2 domains with problems) | 508 | 28.0 | 106 | 26.9 | 1.97 | 1.17; 3.30 |
3 (3 domains with problems) | 687 | 37.8 | 156 | 39.6 | 2.14 | 1.29; 3.54 |
4 (4 domains with problems) | 271 | 14.9 | 102 | 25.9 | 3.55 | 2.10; 5.99 |